首页> 外文期刊>Medical oncology >Thin melanoma and late recurrences: It is never too thin and never too late
【24h】

Thin melanoma and late recurrences: It is never too thin and never too late

机译:稀薄的黑色素瘤和晚期复发:它永远不会太稀薄也不会太迟

获取原文
获取原文并翻译 | 示例
           

摘要

In the absence of risk factors, thin melanomas (TM) present a long-term survival; however, recurrences may occur. We describe the predictive clinicopathological features of patients with metastatic TM. Kaplan-Meier product was performed for the survival analysis, while Cox proportional hazards regression was used to evaluate the effect of the clinicopathological features on disease-free survival (DFS) and overall survival (OS). Median DFS of the entire cohort was 26 months and three patients developed late metastases. Nine patients developed extra-nodal metastases as first recurrence, while cases of positive sentinel lymph node biopsy (SLNB) were not found. DFS and OS varied according to the clinicopathological features, but only ulceration remained the main statistical significance value. According to our results, a hypothetical use of SLNB in TM without other risk factors is not currently feasible. No consensus exists as to which patients with TM are at risk for metastases or late recurrences.
机译:在没有危险因素的情况下,薄型黑色素瘤(TM)可长期存活;但是,可能会再次发生。我们描述了转移性TM患者的预测性临床病理特征。 Kaplan-Meier产品用于生存分析,而Cox比例风险回归用于评估临床病理特征对无病生存(DFS)和总体生存(OS)的影响。整个队列的中位DFS为26个月,三名患者发生了晚期转移。 9例患者首次复发时出现结外转移,而未发现前哨淋巴结活检阳性的病例。 DFS和OS根据临床病理特征而变化,但是仅溃疡仍是主要的统计显着性值。根据我们的结果,假设在TM中使用SLNB而没有其他危险因素目前尚不可行。关于哪些TM患者有转移或晚期复发的风险尚无共识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号